Volume 54, Issue 2

Search all Diabetologia articles

February 2011

35 articles in this issue

Rosiglitazone: a European regulatory perspective
E. Blind
K. Dunder
E. Abadie
Commentary 14 December 2010 Pages: 213 - 218
New aspects of an old drug: metformin as a glucagon-like peptide 1 (GLP-1) enhancer and sensitiser
Y. M. Cho
T. J. Kieffer
Commentary 30 November 2010 Pages: 219 - 222
The stress of starvation: glucocorticoid restraint of beta cell development
L. C. Matthews
N. A. Hanley
Commentary Open access 12 November 2010 Pages: 223 - 226
Gestational diabetes: costs and consequences
R. S. Lindsay
Commentary 26 November 2010 Pages: 227 - 229
Dysglycaemia, dyslipidaemia and hypertension: risk factors primarily focused on the disease or risk estimates primarily focused on the patient?
H. C. Gerstein
Commentary 20 November 2010 Pages: 230 - 232
Cognitive functioning in type 1 diabetes: the Diabetes Control and Complications Trial (DCCT) revisited
B. M. Frier
Commentary 26 November 2010 Pages: 233 - 236
Targeting energy expenditure via fuel switching and beyond
J. G. Geisler
For Debate 17 October 2010 Pages: 237 - 244
Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohort
A. M. Jacobson
C. M. Ryan
and the DCCT/EDIC Research Group
Article 29 August 2010 Pages: 245 - 255
Screening for gestational diabetes mellitus: cost–utility of different screening strategies based on a woman’s individual risk of disease
J. A. Round
P. Jacklin
R. I. G. Holt
Article 31 August 2010 Pages: 256 - 263
External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes
S. van Dieren
L. M. Peelen
J. W. J. Beulens
Article Open access 14 November 2010 Pages: 264 - 270
The relation of low glycaemic index fruit consumption to glycaemic control and risk factors for coronary heart disease in type 2 diabetes
D. J. A. Jenkins
K. Srichaikul
L. A. Leiter
Article Open access 27 October 2010 Pages: 271 - 279
Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study
T. M. E. Davis
R. Ting
on behalf of the FIELD Study investigators
Article 04 November 2010 Pages: 280 - 290
Non-diabetic hyperglycaemia and cardiovascular risk: moving beyond categorisation to individual interpretation of absolute risk
P. Chamnan
R. K. Simmons
S. J. Griffin
Article 23 September 2010 Pages: 291 - 299
Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study
Q. Gong
E. W. Gregg
P. H. Bennett
Article 03 November 2010 Pages: 300 - 307
Immortal time bias and survival in patients who self-monitor blood glucose in the Retrolective Study: Self-monitoring of Blood Glucose and Outcome in Patients with Type 2 Diabetes (ROSSO)
F. Hoffmann
F. Andersohn
Short Communication 19 September 2010 Pages: 308 - 311
Effect of population screening for type 2 diabetes on mortality: long-term follow-up of the Ely cohort
R. K. Simmons
M. Rahman
S. J. Griffin
Article 27 October 2010 Pages: 312 - 319
Associations between the intake of caffeinated and decaffeinated coffee and measures of insulin sensitivity and beta cell function
R. C. Loopstra-Masters
A. D. Liese
A. J. Hanley
Article 03 November 2010 Pages: 320 - 328
Lipoprotein-associated phospholipase A₂ and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes: the Cardiovascular Health Study
T. L. Nelson
A. Kamineni
K. J. Mukamal
Short Communication 20 November 2010 Pages: 329 - 333
Association analysis of Notch pathway signalling genes in diabetic nephropathy
D. Kavanagh
G. J. McKay
the Warren 3/UK GoKinD Study Group
Short Communication 20 November 2010 Pages: 334 - 338
Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice
A. Maida
B. J. Lamont
D. J. Drucker
Article 23 October 2010 Pages: 339 - 349
Genetic evidence of the programming of beta cell mass and function by glucocorticoids in mice
B. Valtat
C. Dupuis
B. Blondeau
Article 21 September 2010 Pages: 350 - 359
Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA_1c levels in human pancreatic islets
B. T. Yang
T. A. Dayeh
C. Ling
Article Open access 23 November 2010 Pages: 360 - 367
Translationally controlled tumour protein (TCTP) is a novel glucose-regulated protein that is important for survival of pancreatic beta cells
F. Diraison
K. Hayward
A. Varadi
Article 10 November 2010 Pages: 368 - 379
Deletion of protein kinase Cδ in mice modulates stability of inflammatory genes and protects against cytokine-stimulated beta cell death in vitro and in vivo
J. Cantley
E. Boslem
T. J. Biden
Article 20 November 2010 Pages: 380 - 389
Adenylyl cyclase 8 is central to glucagon-like peptide 1 signalling and effects of chronically elevated glucose in rat and human pancreatic beta cells
B. Roger
J. Papin
J. Lang
Article 03 November 2010 Pages: 390 - 402
Alx3-deficient mice exhibit decreased insulin in beta cells, altered glucose homeostasis and increased apoptosis in pancreatic islets
M. Mirasierra
A. Fernández-Pérez
M. Vallejo
Article 21 November 2010 Pages: 403 - 414
Delayed onset of hyperglycaemia in a mouse model with impaired glucagon secretion demonstrates that dysregulated glucagon secretion promotes hyperglycaemia and type 2 diabetes
N. Gustavsson
T. Seah
W. Han
Article 27 October 2010 Pages: 415 - 422
BK channels affect glucose homeostasis and cell viability of murine pancreatic beta cells
M. Düfer
Y. Neye
G. Drews
Article 28 October 2010 Pages: 423 - 432
Beta cell function during rapamycin monotherapy in long-term type 1 diabetes
L. Piemonti
P. Maffi
E. Bonifacio
Article 03 November 2010 Pages: 433 - 439
Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes
Y. Wang
Y. Nakagawa
Y. Liu
Article 04 November 2010 Pages: 440 - 450
Comparison of two sulfonylureas with high and low myocardial K_ATP channel affinity on myocardial infarct size and metabolism in a rat model of type 2 diabetes
S. B. Kristiansen
B. Løfgren
H. E. Bøtker
Article 21 November 2010 Pages: 451 - 458
The role of lipid peroxidation products and oxidative stress in activation of the canonical wingless-type MMTV integration site (WNT) pathway in a rat model of diabetic retinopathy
T. Zhou
K. K. Zhou
J-x. Ma
Article Open access 27 October 2010 Pages: 459 - 468
Successful transfer to sulfonylurea therapy in an infant with developmental delay, epilepsy and neonatal diabetes (DEND) syndrome and a novel ABCC8 gene mutation
N. Zwaveling-Soonawala
E. E. Hagebeuk
A. S. van Trotsenburg
Research Letter Open access 26 November 2010 Pages: 469 - 471
Increased fetuin A levels in Helicobacter pylori infection: a missing link between H. pylori and insulin resistance?
A. C. Manolakis
E. K. Tiaka
S. P. Potamianos
Research Letter 30 November 2010 Pages: 472 - 474
Immortal time bias does not invalidate the association of self-monitoring of blood glucose with better survival of patients with type 2 diabetes in the epidemiological study ROSSO (Retrolective Study: Self-monitoring of Blood Glucose and Outcome in Patients with Type 2 Diabetes)
B. Schneider
S. Martin
H. Kolb
Letter 20 November 2010 Pages: 475 - 476

Volume 54, Issue 2

Rosiglitazone: a European regulatory perspective

New aspects of an old drug: metformin as a glucagon-like peptide 1 (GLP-1) enhancer and sensitiser

The stress of starvation: glucocorticoid restraint of beta cell development

Gestational diabetes: costs and consequences

Dysglycaemia, dyslipidaemia and hypertension: risk factors primarily focused on the disease or risk estimates primarily focused on the patient?

Cognitive functioning in type 1 diabetes: the Diabetes Control and Complications Trial (DCCT) revisited

Targeting energy expenditure via fuel switching and beyond

Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohort

Screening for gestational diabetes mellitus: cost–utility of different screening strategies based on a woman’s individual risk of disease

External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes

The relation of low glycaemic index fruit consumption to glycaemic control and risk factors for coronary heart disease in type 2 diabetes

Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study

Non-diabetic hyperglycaemia and cardiovascular risk: moving beyond categorisation to individual interpretation of absolute risk

Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study

Immortal time bias and survival in patients who self-monitor blood glucose in the Retrolective Study: Self-monitoring of Blood Glucose and Outcome in Patients with Type 2 Diabetes (ROSSO)

Effect of population screening for type 2 diabetes on mortality: long-term follow-up of the Ely cohort

Associations between the intake of caffeinated and decaffeinated coffee and measures of insulin sensitivity and beta cell function

Lipoprotein-associated phospholipase A₂ and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes: the Cardiovascular Health Study

Association analysis of Notch pathway signalling genes in diabetic nephropathy

Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice

Genetic evidence of the programming of beta cell mass and function by glucocorticoids in mice

Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA_1c levels in human pancreatic islets

Translationally controlled tumour protein (TCTP) is a novel glucose-regulated protein that is important for survival of pancreatic beta cells

Deletion of protein kinase Cδ in mice modulates stability of inflammatory genes and protects against cytokine-stimulated beta cell death in vitro and in vivo

Adenylyl cyclase 8 is central to glucagon-like peptide 1 signalling and effects of chronically elevated glucose in rat and human pancreatic beta cells

Alx3-deficient mice exhibit decreased insulin in beta cells, altered glucose homeostasis and increased apoptosis in pancreatic islets

Delayed onset of hyperglycaemia in a mouse model with impaired glucagon secretion demonstrates that dysregulated glucagon secretion promotes hyperglycaemia and type 2 diabetes

BK channels affect glucose homeostasis and cell viability of murine pancreatic beta cells

Beta cell function during rapamycin monotherapy in long-term type 1 diabetes

Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes

Comparison of two sulfonylureas with high and low myocardial K_ATP channel affinity on myocardial infarct size and metabolism in a rat model of type 2 diabetes

The role of lipid peroxidation products and oxidative stress in activation of the canonical wingless-type MMTV integration site (WNT) pathway in a rat model of diabetic retinopathy

Successful transfer to sulfonylurea therapy in an infant with developmental delay, epilepsy and neonatal diabetes (DEND) syndrome and a novel ABCC8 gene mutation

Increased fetuin A levels in Helicobacter pylori infection: a missing link between H. pylori and insulin resistance?

Immortal time bias does not invalidate the association of self-monitoring of blood glucose with better survival of patients with type 2 diabetes in the epidemiological study ROSSO (Retrolective Study: Self-monitoring of Blood Glucose and Outcome in Patients with Type 2 Diabetes)

Navigation